Faculty of Health and Life Sciences, School of Applied Social Sciences, De Montfort University, Leicester, UK.
Urologia. 2024 Nov;91(4):819-823. doi: 10.1177/03915603241261813. Epub 2024 Jul 26.
This exploratory study aimed to look into public perceptions of Reversible Inhibition of Sperm Under Guidance (RISUG) as a family planning method in the United Kingdom (UK). It also aimed to discover if there were any sex differences in perceptions between males and females.
Twelve semi-structured interviews were conducted, six with males and six with females, all residents of the UK.
The audio data from the interviews then was transcribed for analysis. An inductive and a semantic thematic analysis was conducted on the data set.
Three main themes were constructed, including: (i) RISUG Hesitancy, (ii) Females perceived benefits of RISUG and (iii) Males perceived concerns regarding RISUG. Hesitancy was related to vaccination hesitancy, females wanted males to have more reproductive autonomy and males placed their concerns through the lens of 'other' males that their may be unintended side effects. Together these three themes represent both perceived risk and overall benefits of the method. However, while randomized control trails have been completed to standard for RISUG, males perceived concerns, suggesting a disconnect between the public's perceptions and professionals understanding of trails.
RISUG was perceived as a viable option for family planning in the future, however trust of the new contraceptive method will need to be fostered among the public in order to effectively transfer knowledge on the potential side effects and the standard of pre-market testing for these. Effective public health messages can result in better education of people concerning the new contraceptive method, including the risks and benefits. By using perceptions to inform health messages around RISUG, researchers and practitioners can learn from potential users how to best address misinformation or concerns, while at the same time building an evidence base for when new male methods reach the contraceptive market.
本探索性研究旨在调查英国（UK）公众对可引导精子可逆抑制（RISUG）作为一种计划生育方法的看法。它还旨在发现男性和女性之间对这种方法的看法是否存在任何性别差异。
进行了 12 次半结构化访谈，其中 6 次与男性进行，6 次与女性进行，所有受访者均为英国居民。
对访谈的音频数据进行了转录以进行分析。对数据集进行了归纳和语义主题分析。
构建了三个主要主题，包括：（i）RISUG 犹豫，（ii）女性认为 RISUG 有好处，（iii）男性认为 RISUG 有顾虑。犹豫与疫苗犹豫有关，女性希望男性有更多的生殖自主权，而男性则通过“其他”男性的视角看待问题，认为可能会有意外的副作用。这三个主题共同代表了该方法的风险和总体益处。然而，尽管已经完成了针对 RISUG 的随机对照试验，但男性的担忧表明，公众对该方法的看法与专业人士对试验的理解之间存在脱节。
RISUG 被认为是未来计划生育的可行选择，然而，为了有效地传递关于潜在副作用和上市前测试标准的知识，需要在公众中建立对这种新避孕方法的信任。有效的公共卫生信息可以使人们更好地了解这种新的避孕方法，包括风险和益处。通过利用公众的看法来为 RISUG 提供健康信息，研究人员和从业者可以从潜在用户那里了解如何最好地解决错误信息或担忧，同时为新的男性避孕方法进入市场建立证据基础。
